Anticholinergic medication vs placebo: Adverse events:urinary retention
Anticholinergics may leads to higher adverse events:urinary retention compared with placebo (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Anticholinergics vs placebo Adverse events:urinary retention · adults with overactive bladder syndrome Anticholinergics may leads to higher adverse events:urinary retention compared with placebo (low certainty). Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (2023) · Cochrane Headline outcomes only | RR 3.52 [2.04, 6.08] | 17 studies · 7862 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults 2023 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.